Dual-energy CT has shown promising results in determining tumor characteristics and treatment effectiveness through spectral data by assessing normalized iodine concentration (nIC), normalized effective atomic number (nZeff), normalized electron density (nED), and extracellular volume (ECV). This study explores the value of quantitative parameters in contrast-enhanced dual-layer spectral detector CT (SDCT) as a potential tool for detecting lymph node activity in lymphoma patients. A retrospective analysis of 55 lymphoma patients with 289 lymph nodes, assessed through 18 FDG-PET/CT and the Deauville five-point scale, revealed significantly higher values of nIC, nZeff, nED, and ECV in active lymph nodes compared to inactive ones ( p < 0.001). Generalized linear mixed models showed statistically significant fixed-effect parameters for nIC, nZeff, and ECV ( p < 0.05). The area under the receiver operating characteristic curve (AUROC) values of nIC, nZeff, and ECV reached 0.822, 0.845, and 0.811 for diagnosing lymph node activity. In conclusion, the use of g nIC, nZeff, and ECV as alternative imaging biomarkers to PET/CT for identifying lymph node activity in lymphoma holds potential as a reliable diagnostic tool that can guide treatment decisions.
Keyphrases
- lymph node
- dual energy
- computed tomography
- contrast enhanced
- image quality
- positron emission tomography
- sentinel lymph node
- neoadjuvant chemotherapy
- diffuse large b cell lymphoma
- magnetic resonance imaging
- pet ct
- end stage renal disease
- diffusion weighted
- ejection fraction
- high resolution
- magnetic resonance
- randomized controlled trial
- prognostic factors
- chronic kidney disease
- squamous cell carcinoma
- diffusion weighted imaging
- combination therapy
- patient reported
- replacement therapy
- artificial intelligence
- deep learning